Literature DB >> 28149773

Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression.

Li-Lun Wang1, Yan-Qin Feng1, Yu-Hong Cheng2.   

Abstract

AIM: To investigate the effect of high mobility group protein box-1 (HMGB1) siRNA on proliferation and apoptosis of retinoblastoma (Rb) cells.
METHODS: The expression of HMGB1 in Rb cells were detected by real-time polymerase chain reaction (RT-PCR) and Western blot. Chemically synthesized HMGB1 siRNA was transfected into Y79 cells. The inhibitory rate was also examined by RT-PCR and Western blot. After HMGB1 siRNA transfection, the cell proliferation was analyzed by MTT, and cell apoptosis was detected by Caspase-3 active detection kit. Cell cycle distribution and apoptosis were detected by flow cytometry.
RESULTS: The expression of HMGB1 significantly elevated in Rb cells (P<0.01). After transfected by siRNA, the HMGB1 protein level of Y79 cells was significantly reduced (P<0.01). After siRNA interference HMGB1, the proportion of proliferating cells reduced, and the proportion of quiescent cells increased (P<0.05). In addition, apoptosis rate of Y79 cells increased from 2.03% to 9.10% after interfering with HMGB1 siRNA (P<0.05).
CONCLUSION: Specific HMGB1 siRNA can inhibit the expression of HMGB1. The effect may be attributed to inhibit the proliferation and promote cell apoptosis.

Entities:  

Keywords:  apoptosis; high mobility group protein box-1; proliferation; retinoblastoma

Year:  2017        PMID: 28149773      PMCID: PMC5225345          DOI: 10.18240/ijo.2017.01.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

1.  Gene therapy: Genie in a vector.

Authors:  Julie Gould
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

2.  Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer.

Authors:  Hiroto Kikuchi; Hiroshi Yagi; Hirotoshi Hasegawa; Yoshiyuki Ishii; Koji Okabayashi; Masashi Tsuruta; Go Hoshino; Atsushi Takayanagi; Yuko Kitagawa
Journal:  J Surg Res       Date:  2014-02-28       Impact factor: 2.192

Review 3.  Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy.

Authors:  L Galluzzi; O Kepp; G Kroemer
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

4.  Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.

Authors:  Jing Zhang; Yu-Bin Kou; Jin-Shui Zhu; Wei-Xiong Chen; Shuang Li
Journal:  Int J Oncol       Date:  2014-01-28       Impact factor: 5.650

5.  Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice.

Authors:  Vengadeshprabhu Karuppagounder; Somasundaram Arumugam; Rajarajan A Thandavarayan; Vigneshwaran Pitchaimani; Remya Sreedhar; Rejina Afrin; Meilei Harima; Hiroshi Suzuki; Mayumi Nomoto; Shizuka Miyashita; Kenji Suzuki; Kenichi Watanabe
Journal:  Int Immunopharmacol       Date:  2014-12       Impact factor: 4.932

6.  MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.

Authors:  Fengmei Shen; Meng-Hsuan Mo; Liang Chen; Shejuan An; Xiaohui Tan; Yebo Fu; Katayoon Rezaei; Zuoren Wang; Lin Zhang; Sidney W Fu
Journal:  J Cancer       Date:  2014-11-21       Impact factor: 4.207

7.  Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.

Authors:  Kamolporn Amornsupak; Tonkla Insawang; Peti Thuwajit; Pornchai O-Charoenrat; Suzanne A Eccles; Chanitra Thuwajit
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

8.  HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes.

Authors:  Sarah Bredeson; John Papaconstantinou; James H Deford; Talar Kechichian; Tariq A Syed; George R Saade; Ramkumar Menon
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

9.  HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.

Authors:  Qingbing Meng; Jie Zhao; Hongbing Liu; Guoyou Zhou; Wensheng Zhang; Xingli Xu; Minqian Zheng
Journal:  Tumour Biol       Date:  2014-08-29

10.  HMGB1-Binding Heptamer Confers Anti-Inflammatory Effects in Primary Microglia Culture.

Authors:  Il-Doo Kim; Ja-Kyeong Lee
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

View more
  4 in total

1.  High mobility group box protein 1 downregulates acid β-glucosidase 1 in synovial fibroblasts from patients with rheumatoid arthritis.

Authors:  Bin Zhang; Hongzhi Wang; Yiwen Wang; Mingfeng Yang; Juanfang Gu; Ming Yao
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  Role of Mitochondria and Lysosomes in the Selective Cytotoxicity of Cold Atmospheric Plasma on Retinoblastoma Cells.

Authors:  Ghazaleh Tahmasebi; Esmaeil Eslami; Parvaneh Naserzadeh; Enayatollah Seydi; Jalal Pourahmad
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

3.  Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies.

Authors:  Ahmad Bereimipour; Leila Satarian; Sara Taleahmad
Journal:  Biomed Res Int       Date:  2021-10-04       Impact factor: 3.411

Review 4.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.